Related by context. All words. (Click for frequent words.) 73 relapsed MM 72 recurrent glioblastoma multiforme 72 relapsing remitting MS RRMS 71 Naive Patients 70 bone marrow reticulin deposition 70 Investigational Treatment 70 non splenectomized 70 ACTEMRA TM 70 alfa 2a 70 CIMZIA TM certolizumab pegol 70 systemic invasive fungal 70 FUSILEV enhances 70 reduce serum phosphate 69 lintuzumab SGN 69 treatment naïve genotype 69 via intradermal injections 69 steroid refractory GvHD 69 myelodysplastic myeloproliferative diseases 69 Abrupt discontinuation 69 stage IIIb IV 69 forodesine 69 steroid refractory 69 treatment naive genotype 69 basiliximab 69 evaluating picoplatin 69 pegylated interferon peg IFN 69 infliximab monotherapy 69 opioid naive 69 adult chronic ITP 69 paclitaxel Taxol R 69 mitoxantrone plus 69 hyperphenylalaninemia HPA due 69 aflibercept VEGF Trap 69 dasatinib Sprycel ® 69 ribavirin RBV 69 antiretroviral naïve 69 pegylated interferon alfa 2a 69 INSPIRE Trial Phase III 68 #mg BID [001] 68 Aflibercept 68 omega interferon 68 docetaxel Taxotere ® 68 Golimumab 68 evaluating tivozanib 68 deep venous thromboses 68 CYT# potent vascular disrupting 68 INTEGRILIN R 68 Vitrasert R 68 pegylated interferon alpha 68 Hormone Refractory Prostate Cancer 68 8mg/kg 68 Amgen Neulasta R 68 Heterozygous Familial Hypercholesterolemia 68 catheter occlusion 68 Ribavirin causes 68 Atypical Hemolytic Uremic Syndrome 68 allogeneic hematopoietic stem cell 68 #mg ATC 68 Amgen Neulasta ® 68 azilsartan medoxomil 68 refractory cutaneous T 68 humanized therapeutic 68 Renal Impairment 68 Elotuzumab 68 receiving XGEVA 68 null responder HCV 68 either acutely decompensated 68 undergoing hematopoietic stem 68 underwent liver transplantation 68 OMP #R# 68 allogeneic HSCT 68 cisplatin gemcitabine 68 ® lenalidomide 68 SPRYCEL ® 68 sorafenib tablets 67 primary immunodeficiency PI 67 HGS ETR1 mapatumumab 67 vapreotide acetate 67 mcg BID 67 5 Fluorouracil 67 Romiplostim 67 decompensated liver disease 67 thetreatment 67 adalimumab Humira 67 zoledronic acid Reclast 67 patients coinfected 67 MGd 67 oral rivaroxaban 67 Meets Primary Endpoint 67 ELACYT 67 Recurrent Glioblastoma 67 develop HBV reactivation 67 Temodar ® 67 moderate renal impairment 67 erlotinib Tarceva ® 67 PLX STROKE targeting 67 ORENCIA ® 67 naïve HCV 67 Phase Ib IIa 67 metastatic GIST 67 transarterial 67 Dementia Related Psychosis 67 BCR ABL inhibitor 67 Peginterferon alfa 2b 67 recurrent metastatic ovarian cancer 67 delivers fluocinolone acetonide FA 67 Complicated Skin 67 rituximab refractory follicular 67 LymphoStat B belimumab 67 tenofovir emtricitabine 67 acetonide FA 67 TAXOTERE ® 67 galiximab 67 Bayer HealthCare Onyx Pharmaceuticals 67 unresectable tumors 67 metastatic colorectal carcinoma 67 anthracycline taxane 67 opioid induced constipation OIC 67 5 fluorouracil leucovorin 67 Peg IFN 67 PEGINTRON TM 67 PREZISTA r 67 relapsing multiple sclerosis 67 acyclovir Lauriad R 67 oropharyngeal candidiasis OPC 67 pegylated interferon alpha 2a 67 comparator arm 67 Sapacitabine 67 alkylating agent 67 recurrent metastatic 66 Phase 2b Clinical Trial 66 Malignant Glioma 66 Relapsed Multiple Myeloma 66 undergoing elective percutaneous 66 unstable angina UA 66 dose escalation phase 66 fistulizing Crohn disease 66 allogeneic hematopoietic cell 66 IMiDs ® compound 66 R entecavir 66 BRIM2 66 refractory chronic lymphocytic 66 IMiDs ® 66 estramustine 66 anthracyclines taxanes 66 Ophena TM 66 humanized interleukin 6 66 Achieves Primary Endpoint 66 ALN VSP Phase 66 Peginterferon 66 immunomodulatory therapy 66 abacavir lamivudine 66 eosinophilic asthma 66 AGILECT R 66 R sorafenib tablets 66 relapsed multiple myeloma 66 retinal vein occlusion induced 66 metastatic ocular 66 advanced carcinoid 66 relapsed refractory AML 66 leukemia AML 66 IMPACT DCM trial 66 Diamyd r 66 phase III isavuconazole 66 Patients Treated With 66 smoldering multiple myeloma 66 Annamycin 66 achieved ACR# 66 venlafaxine XR 66 cyclophosphamide doxorubicin vincristine 66 rituximab refractory 66 dual endothelin receptor antagonist 66 metastatic bladder 66 secondary hyperparathyroidism SHPT 66 Acute Coronary Syndromes ACS 66 acute GvHD 66 TTF Therapy 66 receiving immunosuppressive therapy 66 oral antidiabetic medication 66 Adjunctive 66 achieved CCyR 66 intravenous bolus 66 non resectable metastatic 66 Tibotec Therapeutics division 66 stable angina pectoris 66 Vidaza azacitidine 66 Aryplase 66 Treatment Experienced 66 Pegasys peginterferon alfa 2a 66 recurrent glioblastoma 66 Demonstrates Sustained 66 Temsirolimus 66 selective modulator 66 HCD# [002] 66 APTIVUS ritonavir 66 Patients Receiving 66 nucleoside naive 66 visilizumab 66 refractory NSCLC 66 dose dose escalation 66 MAGE A3 ASCI 66 refractory myeloma 66 Cell Lymphoma CTCL 66 systemic RNAi therapeutic 66 nucleotide analogue 66 tolterodine ER 66 demonstrated antitumor activity 66 Improves Outcomes 66 oral prodrug 66 Relapsed Refractory 66 refractory indolent non 66 Vidaza ® 66 maximally tolerated lipid lowering 66 post herpetic neuralgia PHN 66 relapsed CLL 66 interferon ribavirin 66 ritonavir boosted 66 kidney urologic 66 NAVISTAR R 66 essential thrombocythemia ET 66 nicardipine 66 recurrent malignant glioma 66 EOquin TM 66 clevidipine 66 paclitaxel Taxol ® 66 hypereosinophilic syndrome 66 Kit CD# positive 66 randomized #:#:# 66 Degarelix 66 sorafenib Nexavar 66 chronic hemodialysis 65 esophageal candidiasis 65 CINQUIL 65 CML CP 65 VEGFR2 inhibitor 65 Mg Usa 65 4mg/kg 65 valsartan amlodipine 65 CTAP# 65 antiretroviral naive 65 CIMZIA TM 65 biliary tract cancer 65 weekly intravenous infusions 65 ADP receptor antagonist 65 rheumatoid arthritis psoriatic arthritis 65 COPEGUS R 65 oxaliplatin Eloxatin 65 BCG refractory carcinoma 65 toenail onychomycosis 65 symptomatic BPH 65 unresectable recurrent 65 weekly subcutaneous injections 65 noninvasive outpatient 65 administered intranasally 65 ascending dose 65 atypical Hemolytic Uremic Syndrome 65 antibody MAb 65 Hsp# Inhibitor 65 recurrent glioma 65 prednisone prednisolone plus 65 riociguat 65 generation purine nucleoside 65 ZOLINZA 65 RoACTEMRA 65 Jevtana 65 CTAP# Capsules 65 COPEGUS ribavirin 65 MKC# MT 65 docetaxel Taxotere R 65 CLARITY study 65 q8h 65 serologically active systemic lupus 65 Cloretazine 65 inhalations twice 65 metastatic malignant 65 relapsed leukemia 65 taxane chemotherapy 65 PEGylated Fab fragment 65 cilengitide 65 Belimumab 65 acute peptic ulcer 65 Raptiva r 65 administered subcutaneously 65 CMV seropositive 65 ORENCIA R 65 oral ridaforolimus 65 R rilonacept Injection 65 Sprycel dasatinib 65 FOLFOX6 chemotherapy regimen 65 lenalidomide Revlimid R 65 refractory CLL 65 rFVIIa 65 oral deforolimus 65 Oral Calcitonin 65 Refractory Hodgkin Lymphoma 65 unfractionated heparin UFH 65 transplantation HCT 65 aliskiren amlodipine 65 dose intramuscular 65 certolizumab 65 dirucotide MBP# 65 Valcyte tablets 65 metaglidasen 65 metastatic pancreatic 65 Diabetic Macular Edema DME 65 intravesical infusion therapy 65 myocardial infarction ventricular fibrillation 65 chemoradiation therapy 65 refractory colorectal cancer 65 trastuzumab Herceptin R 65 Folfox 65 oral dual endothelin 65 psoriatic arthritis PsA 65 BARACLUDE ® 65 LHRH receptor positive 65 hereditary deficiency 65 plus dexamethasone 65 asymptomatic metastatic 65 dalteparin 65 metastatic hormone refractory 65 hepatorenal syndrome 65 Crofelemer budesonide foam 65 plus prednisone 65 pyrimidine nucleoside analog 65 administered concomitantly 65 Forodesine HCl 65 AIR CF1 65 Initiate Clinical Trial 65 Accelerated Partial Breast Irradiation 65 atypical hemolytic uremic syndrome 65 nucleoside analog 65 Lipitor #mg 65 plus prednisone prednisolone 65 Mg Uk 65 interferon gamma 1b 65 CK # administered 65 SNT MC# 65 previously untreated follicular 65 chronic myeloid 65 Diabetic Macular Edema 65 cyclophosphamide chemotherapy 65 dexamethasone Decadron 65 Pegloticase 65 cisplatin chemotherapy 65 Methylnaltrexone 65 potentially hepatotoxic 65 class mGluR5 inhibitor 65 R lenalidomide 65 mg administered orally 65 subcutaneous formulation 65 Fludarabine 65 DEB# 65 Bosutinib 65 Budesonide foam crofelemer 65 im peramivir 65 polycythemia vera essential thrombocythemia 65 GAMMAGARD 65 Panzem R NCD 65 haematologic malignancies 65 rALLy clinical trial 65 icatibant 65 metastatic dermatofibrosarcoma protuberans DFSP 65 trastuzumab Herceptin ® 65 non constipating irritable 65 Neovascular AMD 65 DU #b 65 irinotecan cisplatin 65 induced anemia 65 anagrelide 65 insulin glulisine 65 receiving prophylactic anticoagulation 65 desvenlafaxine succinate 65 evaluating Xcytrin 65 known sulfonamide allergy 65 receptor tyrosine kinase inhibitor 65 LymphoStat B TM 65 REMINYL ® 65 mapatumumab 65 cytomegalovirus immune globulin 65 Hydroxyurea 65 mild renal insufficiency 65 Edurant 65 heFH 65 constipation OIC 65 assessing T DM1 65 methylnaltrexone bromide 64 Initiates Enrollment 64 Torisel 64 rhIGF-I/rhIGFBP-3 64 metastatic CRPC 64 subcutaneous methylnaltrexone 64 mRCC 64 5 FU leucovorin 64 Infusion reactions 64 intravenous iv 64 hormone refractory metastatic prostate 64 saline placebo 64 Nebulized 64 adefovir dipivoxil 64 intravenous RSD# 64 approved incretin mimetic 64 dasatinib Sprycel 64 hoFH 64 headache nasopharyngitis 64 somatostatin analog 64 phase IIb clinical 64 Gleevec imatinib 64 biologic antibody 64 motesanib 64 stage IIIb 64 Vascular Disrupting Agent 64 Granted Orphan Drug 64 YONDELIS 64 diabetic kidney 64 Pegylated Interferon 64 orally inhaled migraine 64 SNT-MC#/idebenone 64 epoetin alpha 64 Flu Cy 64 sunitinib Sutent 64 daily subcutaneous injections 64 Heart Transplant Recipients 64 acute mania 64 Gamunex C 64 VELCADE melphalan 64 PEG interferon 64 nilotinib Tasigna ® 64 albiglutide 64 argatroban 64 superficial bladder cancer 64 orally administered inhibitor 64 HIV coinfected 64 Pemetrexed 64 low dose cytarabine 64 peginterferon alfa 64 Hepatocellular Carcinoma HCC 64 Hypertensive adverse reactions 64 sunitinib malate 64 serum phosphorous 64 humanised monoclonal antibody 64 IAP inhibitor 64 Vicriviroc 64 receiving VELCADE 64 mycophenolic acid 64 steroid refractory ulcerative 64 blinded randomized placebo controlled 64 cediranib 64 memantine HCl 64 Allovectin 7 ® 64 Demonstrates Positive 64 GW# [003] 64 ß blockers 64 CHOP chemotherapy 64 colesevelam HCl 64 reversing heparin 64 TEMODAL 64 APTIVUS r 64 blinded placebo controlled 64 Investigational Oral 64 Daclizumab 64 peginterferon alfa 2a Pegasys 64 hepatitis B immune globulin 64 #I TM# 64 mycophenolate mofetil MMF 64 Dasatinib 64 5mg/kg 64 non CF bronchiectasis 64 primary hypercholesterolemia 64 protease inhibitor PI 64 Omacetaxine 64 Major Depressive Disorder MDD 64 Newly Diagnosed Multiple Myeloma 64 psoriasis Crohn disease 64 paclitaxel poliglumex 64 Hodgkin lymphoma HL 64 symptomatic hyponatremia 64 PRN FDA Approves 64 #mg QD [002] 64 hepatitis C HCV 64 Oral Fingolimod 64 intravenous cyclophosphamide 64 nephropathic cystinosis cystinosis 64 containing abacavir 64 overactive bladder syndrome 64 Hedgehog Pathway Inhibitor 64 Treatment Shows Promise 64 pharmacologically active isomer 64 overt nephropathy 64 Treatment Naive Patients 64 morphometric vertebral fractures 64 radiolabeled TM# 64 cyclosporine tacrolimus 64 Initiates Phase III 64 lenalidomide dexamethasone 64 ARIXTRA R 64 severe hepatic dysfunction 64 placebo controlled Phase III 64 Platinol ® 64 hA# 64 intravitreal insert 64 intradermal injections 64 FIRMAGON 64 pegylated liposomal doxorubicin 64 bortezomib Velcade R 64 Vincristine 64 novel VDA molecule 64 evaluating T DM1 64 Chemophase 64 Metastatic Melanoma 64 Cutaneous T 64 IMiDs 64 enzymatically activated within 64 rilonacept 64 titrated glipizide 64 induced macular edema 64 hormone LHRH antagonist 64 everolimus tablets 64 adenosine injection 64 prospectively stratified 64 indolent follicular non 64 systemic juvenile idiopathic 64 evaluating Actimmune 64 aspirin clopidogrel 64 phase IIb trial 64 Prednisone Against Refractory 64 Stage IIIB IV 64 recombinant PSMA vaccine 64 hypertrichosis occurred 64 immunosuppressant drug 64 Microplasmin 64 peginterferon alpha 2a 64 alpha 2a 64 pregabalin Lyrica 64 relapsed refractory multiple myeloma 64 mild hepatic impairment 64 octreotide LAR 64 BARACLUDE R 64 SUPPRELIN R LA 64 cytomegalovirus infection 64 naive HCV 64 KRN# 64 Xelox 64 recurrent GBM 64 sapacitabine CYC# 64 gastrointestinal stromal tumors GIST 64 Viread tenofovir disoproxil fumarate 64 metastatic neuroendocrine tumors 64 metastatic gastric 64 FROVA 64 Zemplar 64 Intravitreal 64 Lupus Nephritis 64 Vitrasert ® 64 Simulect 64 Gemzar gemcitabine 64 Tacrolimus 64 included exfoliative dermatitis 64 oral ribavirin 64 regorafenib 64 vinorelbine tartrate 64 capecitabine Xeloda 64 Severe VOD 64 Emtriva Viread 64 sitagliptin metformin 64 Fondaparinux 64 interferon alpha IFN alpha 64 Azacitidine 64 Nothing Wadden 64 Kinoid 64 Tekamlo 64 undergoing peritoneal dialysis 64 Tramiprosate ALZHEMED TM 64 gemcitabine Gemzar 64 darunavir r 64 brand ciclesonide HFA 64 basal bolus therapy 64 TO AVOID PREGNANCY WHILE 64 thalidomide Thalomid 64 PROCRIT ® 64 chronic ITP patients 64 induce orthostatic hypotension 64 Relapsing Remitting Multiple Sclerosis 64 Muraglitazar 64 venlafaxine ER 64 diabetic neuropathic pain 64 cinacalcet 64 osteoporotic compression fractures 64 Ph + acute lymphoblastic 64 Vandetanib 64 relapsed acute lymphoblastic 64 Brentuximab Vedotin SGN 64 Demonstrate Significant 64 carcinoma mCRC 64 commercialize deforolimus 64 systemic corticosteroid 64 phase IIb study 64 Pivotal Phase III 64 severe hypercholesterolemia 63 Proellex TM 63 R adefovir dipivoxil 63 herpetic keratitis 63 Is Well Tolerated 63 Panzem R 63 Adenoscan R 63 sapropterin dihydrochloride Tablets 63 Lixivaptan 63 Tolvaptan 63 idiopathic thrombocytopenic purpura ITP 63 R abatacept 63 AMEVIVE 63 Copegus ribavirin 63 VANTAS ® 63 Dose Ranging Study 63 Clot busting 63 novel chimeric natriuretic 63 Amigal TM 63 retinal vein occlusion 63 interferon alfa 2a 63 ribavirin therapy 63 sulfonylurea metformin 63 active comparator 63 pharmacogenomic translational research 63 peginterferon ribavirin 63 Personalized Immunotherapy 63 hematological malignancy 63 oral clodronate 63 cardiovascular calcification 63 oral methylnaltrexone 63 severe oral mucositis 63 Central Retinal Vein 63 AVASTIN 63 Motesanib 63 docetaxel Injection Concentrate 63 Teriflunomide 63 PEGINTRON REBETOL combination 63 PD LID 63 Albuferon TM 63 pan histone deacetylase 63 receiving chemoradiation therapy 63 HCV SPRINT 63 Pharmacokinetics PK 63 Myelodysplastic Syndrome MDS 63 Liprotamase 63 Paroxysmal Nocturnal Hemoglobinuria 63 continuous intravenous infusion 63 INVEGA ® 63 homozygous familial hypercholesterolemia 63 Talabostat 63 Adjuvant Treatment 63 investigational monoclonal antibody 63 abacavir Ziagen 63 Cannabinor 63 Eculizumab 63 carboplatin chemotherapy 63 cutaneous T 63 Long Term Efficacy 63 alvespimycin 63 Gliadel Wafer 63 nonmetastatic 63 discontinued Viread 63 thrombin inhibiting aptamer 63 SUTENT ® 63 compound INCB# 63 HIV HCV coinfected 63 injected subcutaneously 63 colorectal cancer liver metastases 63 Sudhir Agrawal D.Phil 63 Known hypersensitivity 63 metastatic renal 63 tumors GIST 63 verteporfin 63 adriamycin 63 sitaxsentan 63 atazanavir ritonavir 63 paclitaxel cisplatin 63 piperacillin tazobactam 63 bortezomib refractory 63 evaluating mipomersen 63 NAVISTAR ® THERMOCOOL ® 63 PEGylated anti 63 q#h 63 bleeding pallor 63 gastrointestinal stromal tumor GIST 63 Noxafil 63 Previously Untreated 63 castrate resistant prostate cancer 63 R Saizen R 63 Host Disease 63 FOLFOX6 63 alefacept 63 lanthanum carbonate 63 Tarceva TM 63 chemotherapy FOLFOX 63 IBS C 63 tenofovir Viread 63 interferon beta therapy 63 carmustine 63 unresectable liver cancer 63 Sustiva efavirenz 63 mcg QD 63 allogeneic transplants 63 #mg #mg #mg [003] 63 interferon beta 1a infertility 63 budesonide foam 63 Advanced Melanoma 63 oral levofloxacin 63 Initiates Phase II 63 p# MAP kinase inhibitor 63 TAXOTERE R 63 octreotide acetate 63 Stereotactic Body Radiation Therapy 63 FluCAM arm 63 immune suppressing medication 63 doxorubicin cyclophosphamide 63 arsenic trioxide injection 63 hematological cancers notably 63 chronic HCV infection 63 Bezielle 63 ® darbepoetin alfa 63 Orphan Status 63 Phase IIb Trial 63 Acute Exacerbations 63 ZACTIMA 63 Inhaled nitric oxide 63 Chronic Lymphocytic Leukemia CLL 63 vitreous floaters 63 Atripla combines 63 corifollitropin alfa 63 Pruvel TM 63 Plaquenil 63 VICTOR E3 63 administered cetrorelix 63 CIMZIA R 63 corticosteroid therapy 63 Femara letrozole 63 canakinumab 63 vitamin B# folic acid 63 ALN HPN 63 calcineurin inhibitor 63 Pazopanib 63 ATRA IV 63 null responder 63 Mycophenolate Mofetil 63 boosted protease inhibitor 63 Phase III Pivotal 63 chronic HCV 63 Refractory Angina 63 nosocomial pneumonia NP 63 neutropenic sepsis 63 Cariprazine 63 PNP inhibitor 63 investigational integrase inhibitor 63 virus HCV protease inhibitor 63 #mg dose [002] 63 Laquinimod 63 ARCALYST ® 63 vascular occlusive diseases 63 Tyrosine Kinase Inhibitor 63 Combination REOLYSIN R 63 oxypurinol 63 Previously Treated 63 Fluvastatin 63 refractory metastatic colorectal cancer 63 Initiate Phase III 63 subcutaneously administered 63 receiving TNF blockers 63 KAPIDEX 63 EDARBI 63 lopinavir ritonavir plus 63 combination antiretroviral therapy 63 sodium stibogluconate 63 blood clot dissolving 63 nasal calcitonin product 63 Pentacel vaccine 63 advanced metastatic renal 63 Certolizumab pegol 63 metastatic renal cell 63 3TC lamivudine Epivir 63 glycoprotein IIb IIIa inhibitor 63 agalsidase alfa 63 colorectal liver metastases 63 Perforomist ™ Inhalation Solution 63 advanced medullary thyroid 63 chronic GVHD 63 FOLFOX chemotherapy 63 Engerix B 63 metastatic HRPC 63 SinuNase TM 63 phase Ib 63 Interferon beta 1a 63 RezularTM 63 Decitabine 63 DOXIL 63 irbesartan 63 CYP#A# substrate 63 platelet inhibitor 63 candesartan cilexetil 63 Targretin capsules 63 PROMACTA 63 placebo controlled dose escalation 63 moderate hepatic impairment 63 Dual Opioid 63 Systemic Sclerosis 63 TroVax ® 63 amoxicillin clavulanate 63 Arranon 63 genotype 1b 63 patients receiving myelosuppressive 63 registrational Phase 63 RAPAMUNE 63 pioglitazone hydrochloride 63 Obatoclax 63 Metastatic Prostate Cancer 63 chronic myocardial ischemia 63 Rilonacept 63 recurrent epithelial ovarian 63 budesonide inhalation suspension 63 neurologic progression 63 non metastatic osteosarcoma 63 3 registrational trial 63 iloprost synthetic compound 63 IONSYS TM 63 5 HT4 63 EGFR TKI 63 #mg QD [001] 63 cyclophosphamide methotrexate 63 Zytiga 63 Amrubicin 63 systemic anaplastic large 63 subcutaneous immunoglobulin 63 HCV NS5B polymerase 63 amalgam fillings mercury vapor 63 APTIVUS R 63 zolmitriptan 63 metformin HCl 63 failure ADHF 63 Camptosar ® 63 exocrine pancreatic insufficiency EPI 63 NMIBC 63 induce remission 63 FOLFIRI alone 63 TELINTRA R 63 oxymorphone ER 63 MenACWY 63 pamidronate 63 headache abdominal pain 63 Desvenlafaxine Succinate 63 Glatiramer Acetate 63 Idiopathic Pulmonary Fibrosis 63 Fludara 63 COREG 63 losartan Cozaar 63 ATACAND 63 uremic pruritus 63 Telithromycin 63 novel synthetic PEGylated 63 complement inhibitor eculizumab 63 occlusion PAO 63 Severe Sepsis 63 multi kinase inhibitor 63 corticosteroid dexamethasone 63 Paraplatin ® 63 r hGH 63 Relapsed Refractory Multiple Myeloma 63 drug belatacept 63 severe exacerbations 63 TNF Tumor Necrosis Factor 63 cyclophosphamide FC 63 standard chemotherapy regimen 63 Hypotension 63 HBeAg negative 63 cisplatin vinorelbine 63 intravenous REOLYSIN 63 subcutaneous enoxaparin 63 High Dose quadruples 63 metastatic colorectal 63 systemic hypotension 63 zoledronate 63 ciprofloxacin hydrochloride 63 pancreatic insufficiency 63 Bone marrow transplant 63 alpha interferons 63 raloxifene Evista 63 aspirin heparin 63 imatinib Gleevec ® 63 Completes Patient Enrollment 63 orally administered synthetic retinoid 63 diagnosed Ph + 63 topical gel formulation 63 Telik logo TELINTRA 63 alemtuzumab Campath 63 RANK Ligand inhibitor 63 Pamidronate 63 Antitumor Activity 63 allogeneic bone marrow 63 pentostatin 63 refractory acute myeloid 63 ACE Inhibitors 63 CEL SCI Phase III 63 non nucleoside inhibitor 63 Kepivance 63 Velcade bortezomib 62 opioid induced bowel dysfunction 62 selective phosphodiesterase 62 formerly LymphoStat B 62 Intravenous immunoglobulin 62 invasive candidiasis 62 Relapsing Multiple Sclerosis 62 Aeolus Pharmaceuticals Announces 62 pegylated interferons 62 Deforolimus 62 budesonide pMDI 62 HuMax EGFr 62 Anti VEGF 62 RAPTIVA 62 unresectable HCC 62 aplastic anemia AA 62 Serostim ® 62 Bacillus Calmette Guerin BCG 62 huN# DM1 62 mg/m2 IV 62 dosing cohort 62 leukemia lymphoma multiple myeloma 62 potent triglyceride lowering 62 Xeloda capecitabine 62 salmeterol fluticasone 62 receiving PEGINTRON 62 recurrent NSCLC 62 developing Bicifadine serotonin 62 relapsed ALL 62 ramipril Altace 62 Prolongs Survival 62 oral anti arrhythmic 62 Avandia Actos 62 IV bolus 62 ChronVac C R 62 CIPN 62 HER2 positive metastatic breast 62 Phase IIIb clinical 62 refractory gout 62 Cytoxan 62 acute peripheral arterial 62 Intravitreal injections 62 targeting miR 62 chronic HBV 62 acute decompensated heart 62 3mg/kg 62 Pivotal Trial 62 First Patient Enrolled 62 psoriasis inflammatory bowel 62 IFN alfa 62 PREZISTA ritonavir 62 CHAMPION PCI 62 Infusion Reactions Severe 62 relapsed Acute Myeloid 62 TMC# C# 62 NATRECOR ® 62 tamoxifen Nolvadex ® 62 metastatic androgen independent 62 systemic ALCL 62 Acute Decompensated Heart Failure 62 Diffuse Large B 62 RELOVAIR ™ 62 novel emulsion formulation 62 efavirenz EFV 62 TNF alpha antagonist 62 Paxil paroxetine 62 KRAS mutant tumors 62 FASLODEX 62 Xeloda ® 62 oral hypoglycemic agent 62 Dacogen injection 62 Glioblastoma Multiforme 62 visceral metastases 62 Kivexa 62 Akt inhibitor 62 intranasal formulation 62 prospectively enrolled 62 Ecallantide 62 KETEK 62 AVONEX ® 62 myeloid metaplasia 62 Gleevec resistant 62 TORISEL TM 62 refractory chronic myeloid 62 TYGACIL 62 miconazole Lauriad ® 62 #.#mg/dL 62 Study Shows Promise 62 chronic eosinophilic leukemia 62 Ketotransdel TM 62 Initiate Phase 62 Successfully Treats 62 Pivotal Phase 62 including acne photodamage 62 Percutaneous vertebroplasty 62 Monopril 62 multicenter randomized placebo controlled 62 inhaled cyclosporine